The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
about
Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer.Thrombomodulin expression regulates tumorigenesis in bladder cancerStandardization of diagnostic biomarker concentrations in urine: the hematuria caveat.Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker dataPreliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladderA pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace.The use of molecular analyses in voided urine for the assessment of patients with hematuria.A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinomaMolecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.Bladder cancer detection and monitoring: assessment of urine- and blood-based marker testsUrinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSIS.A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder CancerGlomerular function in relation to circulating adhesion molecules and inflammation markers in a general population.Detecting bladder cancer using volatile analyses: is this the future?An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer
P2860
Q33692622-ACB94C68-AA5D-4F81-9DF8-1A34D95F8E79Q33733056-A1B41C50-A19F-4347-A013-25CAFDAD2F5DQ34541867-E4E4F64E-8832-4DFD-AD58-5AB04581E324Q34552696-8214573F-01AD-4DD9-8CA5-3341F8EC1FABQ34812142-0F8BD0A6-371F-4264-ABA6-7B2D4573814BQ34828645-7D14D9E8-FFB1-46AE-A511-1B12F9F895EEQ35021819-8F184EAD-CB5A-457C-B8E1-745FDE0EF679Q35341492-A90EB4A4-57AD-45F3-B8BE-AA3D2705CF16Q36190604-164EE6FB-46B7-4D7C-878A-99311A5FBB18Q36770389-AED7C0BF-F3CF-4313-AE5B-5B0754E9E972Q38020241-E1CBF364-62DF-4AEA-8D19-CC57797008A5Q38181600-C954DC16-EAE7-492D-A992-DAF72B3BA11DQ38188561-948843C6-1176-4CF5-B508-0B638E94AF49Q38921522-567412B5-1B34-454D-BE0B-E70D8926C426Q47676702-853D48EC-C74C-452E-B3C4-B9FCA30586C8Q48809230-8D7FFC28-5CCB-4698-86D3-F69053ACD8D1Q58714875-68EC2C24-259F-471A-98C0-D53620B1F50E
P2860
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The impact of biomarkers in mu ...... is in patients with hematuria.
@en
The impact of biomarkers in mu ...... is in patients with hematuria.
@nl
type
label
The impact of biomarkers in mu ...... is in patients with hematuria.
@en
The impact of biomarkers in mu ...... is in patients with hematuria.
@nl
prefLabel
The impact of biomarkers in mu ...... is in patients with hematuria.
@en
The impact of biomarkers in mu ...... is in patients with hematuria.
@nl
P2093
P2860
P356
P1433
P1476
The impact of biomarkers in mu ...... sis in patients with hematuria
@en
P2093
Brian Duggan
Cherith N Reid
Declan O'Rourke
Hugh F O'Kane
Joe M O'Sullivan
John V Lamont
Kate E Williamson
Mark W Ruddock
Michael Stevenson
Neil H Anderson
P2860
P304
P356
10.1002/CNCR.26544
P407
P577
2011-09-14T00:00:00Z